PUBLISHER: TechNavio | PRODUCT CODE: 2172580
PUBLISHER: TechNavio | PRODUCT CODE: 2172580
Global Artificial Heart Market 2026-2030
The global artificial heart market is forecasted to grow by USD 2301.5 mn during 2025-2030, accelerating at a CAGR of 11.9% during the forecast period. The report on the global artificial heart market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements in miniaturization and biocompatibility, rising biventricular heart failure burden and donor shortages, infrastructure expansion and favorable reimbursement frameworks.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 11.1% |
| CAGR | 11.9% |
| Incremental Value | $2301.5 mn |
Technavio's global artificial heart market is segmented as below:
By Product
- Ventricular assist devices
- Heart-lung machines
- Total artificial hearts
- Others
By Application
- Bridge-to-transplant
- Destination therapy
- Bridge-to-decision
- Bridge-to-recovery
By Source
- Internal batteries
- External batteries
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the accelerated regulatory pathways for advanced therapeutics as one of the prime reasons driving the global artificial heart market growth during the next few years. Also, device biocompatibility and durability advancements and regulatory acceleration for next-generation pumps will lead to sizable demand in the market.
The report on the global artificial heart market covers the following areas:
- Global artificial heart market sizing
- Global artificial heart market forecast
- Global artificial heart market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global artificial heart market vendors that include Abbott Laboratories, Berlin Heart GmbH, BiVACOR Inc., Braile Biomedica, BrioHealth Solutions Inc., CorWave SA, ELITE LIFECARE, FineHeart S.A., Getinge AB, Johnson and Johnson, LivaNova PLC, Medtronic Plc, Nipro Medical Corp., Senko Medical Instrument Mfg., Spectrum Medical Ltd., SynCardia Systems LLC, Terumo Corp., Vygon SA. Also, the global artificial heart market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Source
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Artificial Heart Market 2020 - 2024
- Historic Market Size - Data Table on Global Artificial Heart Market 2020 - 2024 ($ million)
- 5.2 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.3 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.4 Source segment analysis 2020 - 2024
- Historic Market Size - Source Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Artificial Heart Market
- 6.2 Impact of Geopolitical Conflicts on Global Artificial Heart Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Product
- 8.1 Market segments
- 8.2 Comparison by Product
- 8.3 Ventricular assist devices - Market size and forecast 2025-2030
- 8.4 Heart-lung machines - Market size and forecast 2025-2030
- 8.5 Total artificial hearts - Market size and forecast 2025-2030
- 8.6 Others - Market size and forecast 2025-2030
- 8.7 Market opportunity by Product
- Market opportunity by Product ($ million)
9 Market Segmentation by Application
- 9.1 Market segments
- 9.2 Comparison by Application
- 9.3 Bridge-to-transplant - Market size and forecast 2025-2030
- 9.4 Destination therapy - Market size and forecast 2025-2030
- 9.5 Bridge-to-decision - Market size and forecast 2025-2030
- 9.6 Bridge-to-recovery - Market size and forecast 2025-2030
- 9.7 Market opportunity by Application
- Market opportunity by Application ($ million)
10 Market Segmentation by Source
- 10.1 Market segments
- 10.2 Comparison by Source
- 10.3 Internal batteries - Market size and forecast 2025-2030
- 10.4 External batteries - Market size and forecast 2025-2030
- 10.5 Market opportunity by Source
- Market opportunity by Source ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 France - Market size and forecast 2025-2030
- 12.4.3 UK - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 Japan - Market size and forecast 2025-2030
- 12.5.2 China - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Singapore - Market size and forecast 2025-2030
- 12.5.6 Taiwan - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Israel - Market size and forecast 2025-2030
- 12.6.3 Australia - Market size and forecast 2025-2030
- 12.6.4 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.5 UAE - Market size and forecast 2025-2030
- 12.6.6 Turkey - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Argentina - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Technological advancements in miniaturization and biocompatibility
- Rising biventricular heart failure burden and donor shortages
- Infrastructure expansion and favorable reimbursement frameworks
- 13.2 Market challenges
- High manufacturing costs and complex perioperative care
- Severe regulatory hurdles and prolonged clinical trial timelines
- Device-related adverse events and hemocompatibility risks
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Accelerated regulatory pathways for advanced therapeutics
- Device biocompatibility and durability advancements
- Regulatory acceleration for next-generation pumps
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 Berlin Heart GmbH
- Berlin Heart GmbH - Overview
- Berlin Heart GmbH - Product / Service
- Berlin Heart GmbH - Key offerings
- SWOT
- 15.6 BiVACOR Inc.
- BiVACOR Inc. - Overview
- BiVACOR Inc. - Product / Service
- BiVACOR Inc. - Key offerings
- SWOT
- 15.7 BrioHealth Solutions Inc.
- BrioHealth Solutions Inc. - Overview
- BrioHealth Solutions Inc. - Product / Service
- BrioHealth Solutions Inc. - Key offerings
- SWOT
- 15.8 CorWave SA
- CorWave SA - Overview
- CorWave SA - Product / Service
- CorWave SA - Key offerings
- SWOT
- 15.9 FineHeart S.A.
- FineHeart S.A. - Overview
- FineHeart S.A. - Product / Service
- FineHeart S.A. - Key offerings
- SWOT
- 15.10 Getinge AB
- Getinge AB - Overview
- Getinge AB - Business segments
- Getinge AB - Key offerings
- Getinge AB - Segment focus
- SWOT
- 15.11 Johnson and Johnson
- Johnson and Johnson - Overview
- Johnson and Johnson - Business segments
- Johnson and Johnson - Key news
- Johnson and Johnson - Key offerings
- Johnson and Johnson - Segment focus
- SWOT
- 15.12 LivaNova PLC
- LivaNova PLC - Overview
- LivaNova PLC - Business segments
- LivaNova PLC - Key offerings
- LivaNova PLC - Segment focus
- SWOT
- 15.13 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- 15.14 Nipro Medical Corp.
- Nipro Medical Corp. - Overview
- Nipro Medical Corp. - Business segments
- Nipro Medical Corp. - Key offerings
- Nipro Medical Corp. - Segment focus
- SWOT
- 15.15 Senko Medical Instrument Mfg.
- Senko Medical Instrument Mfg. - Overview
- Senko Medical Instrument Mfg. - Product / Service
- Senko Medical Instrument Mfg. - Key offerings
- SWOT
- 15.16 SynCardia Systems LLC
- SynCardia Systems LLC - Overview
- SynCardia Systems LLC - Product / Service
- SynCardia Systems LLC - Key offerings
- SWOT
- 15.17 Terumo Corp.
- Terumo Corp. - Overview
- Terumo Corp. - Business segments
- Terumo Corp. - Key news
- Terumo Corp. - Key offerings
- Terumo Corp. - Segment focus
- SWOT
- 15.18 Vygon SA
- Vygon SA - Overview
- Vygon SA - Product / Service
- Vygon SA - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
